Suchergebnisse
Can Better Japan Profitability Support Aflac's Q2 Earnings Beat?
Insurance provider Aflac Incorporated AFL is set to report its second-quarter 2026 results on Aug. 6, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings
Can Higher Occupancy Help Encompass Health Counter Rising Costs in Q2?
Hospital operator Encompass Health Corporation EHC is set to report second-quarter 2026 results on Aug. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s
Can MetLife Deliver a Q2 Earnings Beat on Group Benefits Strength?
Insurance provider MetLife, Inc. MET is set to report its second-quarter 2026 results on Aug. 5, 2026, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS)?
Launched on November 1, 2006, the Invesco S&P 500 Equal Weight Consumer Staples ETF (RSPS) is a passively managed exchange traded fund designed to provide a broad exposure to the Consumer Staples -
Is JPMorgan Diversified Return Emerging Markets Equity ETF (JPEM) a Strong ETF Right Now?
Designed to provide broad exposure to the Broad Emerging Market ETFs category of the market, the JPMorgan Diversified Return Emerging Markets Equity ETF (JPEM) is a smart beta exchange traded fund
Should Invesco RAFI US 1500 Small-Mid ETF (PRFZ) Be on Your Investing Radar?
Launched on September 20, 2006, the Invesco RAFI US 1500 Small-Mid ETF (PRFZ) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Blend segment of the
Buy Microchip Stock Before Q1 Earnings? Here's What to Know
Microchip MCHP is set to report its first-quarter fiscal 2027 results on Aug. 6.For the to-be-reported quarter, MCHP expects revenues between $1.442 billion and $1.469 billion. The Zacks Consensus
Should You Buy, Hold or Sell Realty Income Stock Before Q2 Earnings?
Realty Income Corporation O, a leader in the net lease sector, is slated to release second-quarter 2026 results on Aug. 5, after market close. The Zacks Consensus Estimate for the to-be-reported
Travere Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Travere Therapeutics, Inc.? Here are five stocks we like better.
- Record FILSPARI performance: Travere reported $169.6 million in total second-quarter revenue
Should You Invest in the Global X U.S. Infrastructure Development ETF (PAVE)?
The Global X U.S. Infrastructure Development ETF (PAVE) was launched on March 6, 2017, and is a passively managed exchange traded fund designed to offer broad exposure to the Utilities -
Is Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) a Strong ETF Right Now?
Designed to provide broad exposure to the Style Box - Mid Cap Blend category of the market, the Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) is a smart beta exchange traded fund launched on
Here's What Key Metrics Tell Us About Medline (MDLN) Q2 Earnings
For the quarter ended June 2026, Medline (MDLN) reported revenue of $7.69 billion, representing no change compared to the same period last year. EPS came in at $0.50, compared to $0 in the year-ago
Global Partners Gears Up for Q2 Earnings: What's in the Cards?
Global Partners LP GLP is set to release second-quarter 2026 results on Aug. 7. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of $1.24 per share on revenues of
Will Investment Income Headwinds Weigh on AIG's Q2 Results?
Insurance provider American International Group, Inc. AIG is set to report its second-quarter 2026 results on Aug. 6, after the closing bell. The Zacks Consensus Estimate for the to-be-reported
Should Investors Chase LMT Stock After Its 15.5% Three-Month Gain?
Lockheed Martin’s LMT shares have risen 15.5% over the past three months, outperforming the Zacks Aerospace-Defense industry’s growth of 12.2%. The company’s record backlog, expanding munitions
BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus
Beam Therapeutics BEAM incurred a loss of $1.18 per share in the second quarter of 2026, wider than the Zacks Consensus Estimate of a loss of $1.00. The company had reported a loss of $1.00 per
Why Ralph Lauren (RL) is Poised to Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ralph Lauren (RL), which belongs to the
Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar?
The Invesco S&P 100 Equal Weight ETF (EQWL) was launched on December 1, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Large Cap Blend segment of the
Should Schwab U.S. Large-Cap Value ETF (SCHV) Be on Your Investing Radar?
Launched on December 11, 2009, the Schwab U.S. Large-Cap Value ETF (SCHV) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Value segment of the US
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Launched on June 19, 2006, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of


